{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:56:55Z","timestamp":1762376215527,"version":"3.44.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T00:00:00Z","timestamp":1495411200000},"content-version":"vor","delay-in-days":51,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1053\/j.seminhematol.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T03:19:15Z","timestamp":1491448755000},"page":"69-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Practical considerations for diagnosis and management of patients and carriers"],"prefix":"10.1053","volume":"54","author":[{"given":"Charlotte M.","family":"Niemeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mecucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2017.04.002_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1182\/asheducation-2016.1.302","article-title":"Germ line mutations associated with leukemias","author":"Porter","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-016-0432-0","article-title":"Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders","volume":"11","author":"Latger-Cannard","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib4","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib5","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2013-04-499319","article-title":"ANKRD26-related thrombocytopenia and myeloid malignancies","volume":"122","author":"Noris","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib8","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","article-title":"Cancer in dyskeratosis congenita","volume":"113","author":"Alter","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib9","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa041331","article-title":"Mutation of CEBPA in familial acute myeloid leukemia","volume":"351","author":"Smith","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2015-10-676098","article-title":"Novel germ line DDX41 mutations define families with a lower age of MDS\/AML onset and lymphoid malignancies","volume":"127","author":"Lewinsohn","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ajhg.2012.03.020","article-title":"Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia","volume":"90","author":"Kirwan","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib12","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.3380","article-title":"Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies","volume":"47","author":"Saliba","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1200\/JCO.2013.50.9257","article-title":"American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers","volume":"32","author":"Lu","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.clml.2016.04.001","article-title":"Evaluation of patients and families with concern for predispositions to hematologic malignancies within the Hereditary Hematologic Malignancy Clinic (HHMC)","volume":"16","author":"DiNardo","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib15","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2008.16.5563","article-title":"Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia","volume":"26","author":"Pabst","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3324\/haematol.2015.137711","article-title":"Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome","volume":"101","author":"Nov\u00e1kov\u00e1","year":"2016","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2016.07.002","article-title":"Transcription factor defects causing platelet disorders","volume":"31","author":"Daly","year":"2017","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"volume":"vol 2","year":"2008","author":"Baumann","key":"10.1053\/j.seminhematol.2017.04.002_bib20"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib21","unstructured":"Buonocore F, Peter K\u00fchnen P, Suntharalingham JP, et al. Dynamic genomic changes rescue severe SAMD9-related growth restriction in humans. J Clin Invest [in press]. Epub ahead of print March 27, 2017."},{"key":"10.1053\/j.seminhematol.2017.04.002_bib22","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2016-10-743302","article-title":"Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS and neurological symptoms","volume":"129","author":"Tesi","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib23","doi-asserted-by":"crossref","first-page":"e26454","DOI":"10.1002\/pbc.26454","article-title":"Novel recurrent chromosome anomalies in Shwachman-Diamond syndrome","volume":"00","author":"Valli","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib24","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1182\/blood-2016-01-583625","article-title":"How I treat MDS and AML in Fanconi anemia","volume":"127","author":"Peffault de Latour","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrg3246","article-title":"The telomere syndromes","volume":"13","author":"Armanios","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/bjh.14461","article-title":"Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition","volume":"176","author":"Valdez","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib27","article-title":"Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome\/acute leukemia predisposition syndromes","author":"Guidugli","year":"2017","journal-title":"Leukemia. Epub ahead of print"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/leu.2009.210","article-title":"Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD\/AML syndrome","volume":"24","author":"Jongmans","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib29","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2016-05-670240","article-title":"How I diagnose and manage individuals at risk for inherited myeloid malignancies","volume":"128","author":"Churpek","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib30","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1182\/blood.V87.9.4015.bloodjournal8794015","article-title":"Utility of fingernail DNA for evaluation of chimerism after bone marrow transplantation and for diagnostic testing for transfusion-associated graft-versus-host disease","volume":"87","author":"Uchida","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.seminoncol.2016.10.003","article-title":"Genetic predisposition to leukemia and other hematologic malignancies","volume":"43","author":"Feurstein","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia","volume":"464","author":"Raaijmakers","year":"2010","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib34","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1200\/JCO.2016.68.4316","article-title":"Conflicting interpretation of genetic variants and cancer risk by commercial laboratories as assessed by the prospective registry of multiplex testing","volume":"34","author":"Balma\u00f1a","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib35","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-06-716704","article-title":"Discussing and managing hematologic germ line variants","volume":"128","author":"Kohlmann","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.20892\/j.issn.2095-3941.2016.0002","article-title":"Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing","volume":"13","author":"Stanislaw","year":"2016","journal-title":"Cancer Biol Med"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/cncr.29027","article-title":"Parent decision-making around the genetic testing of children for germline TP53 mutations","volume":"121","author":"Alderfer","year":"2015","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib38","article-title":"Factors influencing the decision-making process and long-term interpersonal outcomes for parents who undergo preimplantation genetic diagnosis for Fanconi anemia: a qualitative investigation","author":"Haude","year":"2016","journal-title":"J Genet Couns"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.30581","article-title":"Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics","author":"Johnson","year":"2017","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib40","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2015-04-641100","article-title":"Genomic analysis of germ line and somatic variants in familial myelodysplasia\/acute myeloid leukemia","volume":"126","author":"Churpek","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/10428194.2015.1115041","article-title":"Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults","volume":"57","author":"Babushok","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1586\/17474086.2014.959923","article-title":"Prognosis and management of acute myeloid leukemia in patients with Down syndrome","volume":"7","author":"Caldwell","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/leu.2010.297","article-title":"Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study","volume":"25","author":"Strahm","year":"2011","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib44","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/MOH.0000000000000290","article-title":"Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita","volume":"23","author":"Elmahadi","year":"2016","journal-title":"Curr Opin Hematol"},{"issue":"12","key":"10.1053\/j.seminhematol.2017.04.002_bib45","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.bbmt.2014.08.004","article-title":"Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"20","author":"Grossman","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib46","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2016.310","article-title":"Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation","volume":"31","author":"Berger","year":"2017","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib47","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0140-6736(03)14797-6","article-title":"Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA","volume":"362","author":"Fogarty","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib48","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1182\/blood-2008-05-156745","article-title":"Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy","volume":"112","author":"Owen","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib49","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib50","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood.V126.23.1679.1679","article-title":"A targeted next-generation sequencing mutation panel for pediatric acute myeloid leukemia and myelodysplastic syndrome (MDS) detects potential additional driver mutations in pediatric GATA2-MDS","volume":"126","author":"Fisher","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.V126.23.299.299","article-title":"Somatic genetic and epigenetic architecture of myelodysplastic syndromes arising from GATA2 deficiency","volume":"126","author":"Pastor Loyola","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib52","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1038\/ncomms5770","article-title":"Recurrent CDC25C mutations drive malignant transformation in FPD\/AML","volume":"5","author":"Yoshimi","year":"2014","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2017.04.002_bib53","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1038\/bcj.2015.81","article-title":"Genetic basis of myeloid transformation in familial platelet disorder\/acute myeloid leukemia patients with haploinsufficient RUNX1 allele","volume":"6","author":"Sakurai","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1053\/j.seminhematol.2017.04.002_bib54","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","article-title":"Danazol treatment for telomere diseases","volume":"374","author":"Townsley","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196317300434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196317300434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:26:08Z","timestamp":1758522368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196317300434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0037196317300434"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2017.04.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical considerations for diagnosis and management of patients and carriers","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}